Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies

Johannes P. van Hooff*, Rita R. Alloway, Pavel Trunecka, Michel Mourad

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E1-E12
JournalClinical Transplantation
Issue number1
Publication statusPublished - 2011


  • calcineurin inhibitor
  • heart transplantation
  • immunosuppressant
  • kidney transplantation
  • liver transplantation
  • long-term effects
  • tacrolimus

Cite this